Skip to main content
. Author manuscript; available in PMC: 2015 Mar 19.
Published in final edited form as: Vaccine. 2008 Aug 19;26(0 10):K17–K28. doi: 10.1016/j.vaccine.2008.06.021

Table 5.

Summary of epidemiological studies and reviews on HPV-related cancers other than cervical, in men and in benign conditions.

Code 1st author, Journal Year; Vol.: pages
References from Table 1: Epidemiological traits of HPV and cancers other than cervical

a1 IARC. Cancer Incidence in Five Continents, Vol. IX. IARC Scientific Publications No.160, Lyon, IARC. 2007
a2 IARC Monographs on the evaluation of carcinogenic risk to humans. Human Papillomavirus. Vol. 90, Lyon, IARC. 2007
a3 Lont AP et al, Int J Cancer. 2006;119(5):1078-81
a4 D’Souza G et al, N Engl J Med. 2007;356(19):1944-56
a5 Kreimer AR et al, Cancer Epidemiol Biomarkers Prev. 2005;14(2):467-75

References from Table 2: Risk of vulvar and vaginal cancer associated with HPV-16,-18, -33 antibodies: case-control studies of type-specific HPV seropositivity and pre-cancer and cancer

b1 Carter JJ et al, Cancer Res. 2001;61(5):1934-40
b2 Madeleine MM et al, J Natl Cancer Inst. 1997;15;89(20):1516-23
b3 Hildesheim A et al, Obstet Gynecol. 1997;90(5):748-54
b4 Sun Y et al, Gynecol Oncol. 1996;63(2):200-3
b5 Daling JR et al, Gynecol Oncol. 2002;84(2):263-70
b6 Bjorge T et al, BMJ 1997;315:646–9

References from Table 3: HPV DNA prevalence in ano-genital warts

c1 Grce M et al, Anticancer Res. 2000;20(3B):2097-102
c2 Skerlev M et al, Clin Dermatol. 2002;20(2):173-8
c3 Labropoulou V et al, J Med Virol. 1994;42(3):259-63
c4 Potocnik M et al, Acta Dermatovenerol Alp Panonica Adriat. 2007;16(3):91-6, 98
c5 Luk CH et al, Abstract PS8-01. 24th International Papillomavirus Conference, Beijing, China, 2007. Abstracts book
c6 Greer CE et al, J Clin Microbiol. 1995;33(8):2058-63
c7 De Marco F et al, J Exp Clin Cancer Res. 2001;20(3):377-83
c8 Brown DR et al, J Clin Microbiol. 1999;37(10):3316-22
C9 Sanclemente G et al, J Eur Acad Dermatol Venereol. 2007;21(8):1054-60
c10 Cavazza Porro ME et al, Abstract PS12-04. 24th International Papillomavirus Conference, Beijing, China, November 2007. Abstracts book

References from Table 4. HPV DNA type distribution in subjects with recurrent respiratory papillomatosis

d1 Gomez MA 1995;553: 213–217 et al., 1995
d2 Levi JE et al, Am J Pathol. 1989;135(6):1179-84
d3 Draganov P et al, Int J Pediatr Otorhinolaryngol. 2006;70(3):469-73
d4 Fu M et al, Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2000;14(7):317-9
d5 Sun AK, Zhonghua Er Bi Yan Hou Ke Za Zhi. 1993;28(5):297-9, 315
d6 Lindeberg J et al, Clin Otolaryngol Allied Sci. 1990;15(4):367-71
d7 Dickens P et al, J Pathol. 1991;165(3):243-6
d8 Velyvyte D et al, Medicina (Kaunas). 2002;38(5):499–504
d9 Peñaloza-Plascencia M et al, Arch Otolaryngol Head Neck Surg. 2000;126(9):1119-23
d10 Obchinnikov IuM et al, Vestn Otorinolaringol. 2004;(3):29-33.
d11 Padayachee A et al, Int J Pediatr Otorhinolaryngol. 1993;26(2):141-7.
d12 Szeps M et al, J Gen Virol. 2005;86(Pt 6):1695-702.
d13 Ushikai M et al, Jpn J Cancer Res. 1994;85(7):699–703.
d14 Maloney EM et al, Arch Otolaryngol Head Neck Surg. 2006;132(7):711-5.
d15 Rabah R et al, Pediatr Dev Pathol. 2001;4(1):68–72.
d16 Pou AM et al, Ann Otol Rhinol Laryngol. 1995;104(10 Pt 1):758–62.
d17 Bello de Afford M et al, RFM. 2001, vol.24, no.1, p.62–65